Molecular surveillance for artemisinin resistance in Africa

The Lancet Infectious Diseases

Volumn 14, Issue 8, 2014, Pages 668-670

  Roper, Cally ^a   Alifrangis, Michael ^b,c   Ariey, Frederic ^d   Talisuna, Ambrose ^f   Menard, Didier ^g   Mercereau Puijalon, Odile ^e   Ringwald, Pascal ^h  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

^d INSTITUT PASTEUR   (France)

^e Parasitology Mycology Department   (France)

^f KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^g INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; CHLOROQUINE; K 13; MOLECULAR MARKER; PYRIMETHAMINE; SULFADOXINE;

AFRICA SOUTH OF THE SAHARA; CAMBODIA; CLINICAL EFFECTIVENESS; DECISION MAKING; GENE LOCUS; MALARIA FALCIPARUM; MOLECULAR MECHANICS; NOTE; PARASITE CLEARANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AFRICA; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; EPIDEMIOLOGICAL MONITORING; GENETIC MARKERS; GENOTYPING TECHNIQUES; HUMANS; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; YOUNG ADULT;

EID: 84904678722     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70826-6     Document Type: Note

References (12)

1. Dondorp AM, Nosten F, Poravuth Y, et al. Artemisinin Resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361:455-467.
2. Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014, 505:50-55.
3. Wootton JC, Feng X, Ferdig MT, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.
4. Roper C, Pearce R, Nair S, et al. Intercontinental spread of pyrimethamine resistance in malaria parasites. Science 2004, 305:1124.
5. Mita T, Venkatesan M, Ohashi J, et al. Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis 2011, 204:1980-1988.
6. WHO Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa WHO, (accessed June 27, 2014). http://www.who.int/malaria/news/WHO_policy_recommendation_IPTi_032010.pdf.
7. Draft recommendations on intermittent preventive treatment in pregnancy WHO evidence review group on intermittent preventive treatment (IPT) of malaria in pregnancy, (accessed June 27, 2014). http://www.who.int/malaria/mpac/mpac_sep13_erg_ipt_malaria_pregnancy_report.pdf.
8. Global plan for artemisinin resistance containment WHO, Roll Back MalariaRoll Back Malaria, (accessed June 27, 2014). http://apps.who.int/iris/bitstream/10665/44482/1/9789241500838_eng.pdf?ua=1.
9. Huang Z, Tatem AJ Global malaria connectivity through air travel. Malaria J 2013, 2:269.
10. Naidoo I, Roper C Mapping 'partially resistant', fully resistant' and 'super resistant' malaria. Trends Parasitol 2013, 29:505-515.
11. Talisuna AO, Karema C, Ogutu B, et al. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis 2012, 12:888-896.
12. Preston MD, Assefa SA, Ocholla H PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation. J Infect Dis 2014, 209:1808-1815.